Microbix Biosystems (TSE:MBX) Stock Price Passes Below 50 Day Moving Average – What’s Next?

Microbix Biosystems Inc. (TSE:MBX) passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.30 and traded as low as C$0.28. Microbix Biosystems shares last traded at C$0.28, with a volume of 70,061 shares changing hands.

Microbix Biosystems Stock Performance

The stock’s 50-day moving average price is C$0.30 and its 200 day moving average price is C$0.27. The firm has a market cap of C$39.72 million, a P/E ratio of -8.06 and a beta of 0.76. The company has a debt-to-equity ratio of 27.69, a current ratio of 6.89 and a quick ratio of 5.57.

Microbix Biosystems (TSE:MBX) last released its earnings results on Thursday, August 13th. The company reported C($0.01) earnings per share for the quarter. Microbix Biosystems had a negative net margin of 31.72% and a negative return on equity of 18.83%. The business had revenue of C$4.06 million during the quarter. As a group, equities analysts predict that Microbix Biosystems Inc. will post 0.02 EPS for the current year.

Microbix Biosystems Company Profile

Microbix Biosystems Inc creates proprietary biological products for human health, with over 120 skilled employees and revenues of C$ 18.6 million in its last reported fiscal year (2025). It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ¿ ) and reference materials (QUANTDx ¿ ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows.